These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35319387)

  • 1. 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)- 4-Piperidone Hydrochloride and Related Compounds: Potent Cytotoxins Demonstrate Greater Toxicity to Neoplasms than Non- Malignant Cells.
    Roayapalley PK; Dimmock JR; Sakagami H; Okudaira N; Sharma RK; Das U
    Med Chem; 2022; 18(9):1001-1012. PubMed ID: 35319387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells.
    Hossain M; Roayapalley PK; Sakagami H; Satoh K; Bandow K; Das U; Dimmock JR
    Medicines (Basel); 2022 Jun; 9(6):. PubMed ID: 35736248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells.
    Pati HN; Das U; Quail JW; Kawase M; Sakagami H; Dimmock JR
    Eur J Med Chem; 2008 Jan; 43(1):1-7. PubMed ID: 17499885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts.
    Roayapalley PK; Dimmock JR; Contreras L; Balderrama KS; Aguilera RJ; Sakagami H; Amano S; Sharma RK; Das U
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy.
    Das U; Sakagami H; Chu Q; Wang Q; Kawase M; Selvakumar P; Sharma RK; Dimmock JR
    Bioorg Med Chem Lett; 2010 Feb; 20(3):912-7. PubMed ID: 20064715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones.
    Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR
    Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships.
    Das S; Roayapalley PK; Sakagami H; Umemura N; Gorecki DKJ; Hossain M; Kawase M; Das U; Dimmock JR
    Medicines (Basel); 2024 Jan; 11(1):. PubMed ID: 38248717
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel 3,5-bis(arylidene)-4-oxo-1-piperidinyl dimers: structure-activity relationships and potent antileukemic and antilymphoma cytotoxicity.
    Santiago-Vazquez Y; Das S; Das U; Robles-Escajeda E; Ortega NM; Lema C; Varela-Ramírez A; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2014 Apr; 77():315-22. PubMed ID: 24657568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic Tumour-Selective 1,5-Diaryl-3-Oxo-1,4-Pentadienes Mounted on a Piperidine Ring.
    Roayapalley PK; Sakagami H; Satoh K; Amano S; Bandow K; Aguilera RJ; Hernandez KGC; Schiaffino Bustamante AY; Dimmock SG; Sharma RK; Das U; Dimmock JR
    Medicines (Basel); 2021 Dec; 8(12):. PubMed ID: 34940290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-Benzylidene-2-[4-(pyridin-3-ylcarboxy)benzylidene]cyclohexanones: A novel cluster of tumour-selective cytotoxins.
    Panda AK; Das U; Umemura N; Sakagami H; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Roayapalley PK; Dimmock JR
    Bioorg Med Chem Lett; 2017 Apr; 27(7):1611-1615. PubMed ID: 28238612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidones and related compounds.
    Dimmock JR; Jha A; Zello GA; Quail JW; Oloo EO; Nienaber KH; Kowalczyk ES; Allen TM; Santos CL; De Clercq E; Balzarini J; Manavathu EK; Stables JP
    Eur J Med Chem; 2002 Dec; 37(12):961-72. PubMed ID: 12660021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: a topographical study of some novel potent cytotoxins.
    Jha A; Mukherjee C; Prasad AK; Parmar VS; Clercq ED; Balzarini J; Stables JP; Manavathu EK; Shrivastav A; Sharma RK; Nienaber KH; Zello GA; Dimmock JR
    Bioorg Med Chem; 2007 Sep; 15(17):5854-65. PubMed ID: 17562365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5-Bis(3-alkylaminomethyl-4-hydroxybenzylidene)-4-piperidones: A Novel Class of Potent Tumor-Selective Cytotoxins.
    Karki SS; Das U; Umemura N; Sakagami H; Iwamoto S; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Dimmock JR
    J Med Chem; 2016 Jan; 59(2):763-9. PubMed ID: 26727215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Conjugated Unsaturated Ketones with Submicromolar Potencies Towards some Leukemic and Colon Cancer Cells.
    Das S; Gul HI; Das U; Balzarini J; Dimmock SG; Dimmock JR
    Med Chem; 2019; 15(4):430-438. PubMed ID: 30324886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells.
    Das U; Doroudi A; Inci Gul H; Pati HN; Kawase M; Sakagami H; Chu Q; Stables JP; Dimmock JR
    Bioorg Med Chem; 2010 Mar; 18(6):2219-2224. PubMed ID: 20189402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity.
    Hossain M; Das S; Das U; Doroudi A; Zhu J; Dimmock JR
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126878. PubMed ID: 31864797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties.
    Das S; Das U; Selvakumar P; Sharma RK; Balzarini J; De Clercq E; Molnár J; Serly J; Baráth Z; Schatte G; Bandy B; Gorecki DK; Dimmock JR
    ChemMedChem; 2009 Nov; 4(11):1831-40. PubMed ID: 19802855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity.
    Chhikara A; Roayapalley PK; Sakagami H; Amano S; Satoh K; Uesawa Y; Das U; Das S; Borrego EA; Guerena CD; Hernandez CR; Aguilera RJ; Dimmock JR
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids.
    Das S; Das U; Sakagami H; Hashimoto K; Kawase M; Gorecki DK; Dimmock JR
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6464-8. PubMed ID: 20889340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins.
    Das S; Das U; Varela-Ramírez A; Lema C; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR
    ChemMedChem; 2011 Oct; 6(10):1892-9. PubMed ID: 21826795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.